Found 202 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2020
R. A. Schmidt, Zaki, A. Al, Desilet, N., Szefer, E., Ratnaweera, N., Peterson, E., and Y Y Lee, A., Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism., Thromb Res, vol. 188, pp. 106-114, 2020.
E. J. Anderson, Lai, L., Wrammert, J., Kabbani, S., Xu, Y., Priyamvada, L., Hill, H., Goll, J. B., Jensen, T. L., Kao, C., Yildirim, I., Rouphael, N., Jackson, L., and Mulligan, M. J., Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine., Vaccines (Basel), vol. 8, no. 1, 2020.
S. Ge, Mendley, S. R., Gerhart, J. G., Melloni, C., Hornik, C. P., Sullivan, J. E., Atz, A., Delmore, P., Tremoulet, A., Harper, B., Payne, E., Lin, S., Erinjeri, J., Cohen-Wolkowiez, M., and Gonzalez, D., Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents., Clin Transl Sci, 2020.
C. E. H. Barber, Marshall, D. A., Szefer, E., Barnabe, C., Shiff, N. J., Bykerk, V., Homik, J., J Thorne, C., Ahluwalia, V., Benseler, S., Mosher, D., Twilt, M., and Lacaille, D., A population-based approach to reporting system-level performance measures for rheumatoid arthritis care., Arthritis Care Res (Hoboken), 2020.
J. K. Legardy-Williams, Carter, R. J., Goldstein, S. T., Jarrett, O. D., Szefer, E., Fombah, A. E., Tinker, S. C., Samai, M., and Mahon, B. E., Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola., Emerg Infect Dis, vol. 26, no. 3, pp. 541-548, 2020.
K. E. Trocin, Weinstein, N. I., Oga, E. A., Mark, K. S., and Coleman-Cowger, V. H., Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women., J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
2019
T. Schonfeld and Rasmussen, L. M., Partnering, Not Enduring: Citizen Science and Research Participation., Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
I. U. Scott, VanVeldhuisen, P. C., Barton, F., Oden, N. L., Ip, M. S., Blodi, B. A., Worrall, M., and Fish, G. E., Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial, JAMA Ophthalmol, vol. 137, no. 8, pp. 932-938, 2019.
G. An, Murry, D. J., Gajurel, K., Bach, T., Deye, G., Stebounova, L. V., Codd, E. E., Horton, J., Gonzalez, A. E., Garcia, H. H., Ince, D., Hodgson-Zingman, D., Nomicos, E. Y. H., Conrad, T., Kennedy, J., Jones, W., Gilman, R. H., and Winokur, P., Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
S. L. Hillier, Ferrieri, P., Edwards, M., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H., and Baker, C. J., A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III, Clin Infect Dis, vol. 68, no. 12, pp. 2079-2086, 2019.
M. E. Horwitz, Wease, S., Blackwell, B., Valcarcel, D., Frassoni, F., Boelens, J. Jan, Nierkens, S., Jagasia, M., Wagner, J. E., Kuball, J., Koh, L. Piu, Majhail, N. S., Stiff, P. J., Hanna, R., Hwang, W. Y. K., Kurtzberg, J., Cilloni, D., Freedman, L. S., Montesinos, P., and Sanz, G., Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide., J Clin Oncol, vol. 37, no. 5, pp. 367-374, 2019.
E. J. Thompson, Wu, H., Melloni, C., Balevic, S., Sullivan, J. E., Laughon, M., Clark, K. M., Kalra, R., Mendley, S., Payne, E. H., Erinjeri, J., Gelber, C. E., Harper, B., Cohen-Wolkowiez, M., and Hornik, C. P., Population Pharmacokinetics of Doxycycline in Children., Antimicrob Agents Chemother, 2019.
C. P. Hornik, Yogev, R., Mourani, P. M., Watt, K. M., Sullivan, J. E., Atz, A. M., Speicher, D., Al-Uzri, A., Adu-Darko, M., Payne, E. H., Gelber, C. E., Lin, S., Harper, B., Melloni, C., Cohen-Wolkowiez, M., and Gonzalez, D., Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents., J Clin Pharmacol, vol. 59, no. 12, pp. 1606-1619, 2019.
V. H. Coleman-Cowger, Peters, E. N., Oga, E. A., Mulatya, C. M., and Mark, K., Prenatal Opioid Use: Characterization of Patients Presenting to Two Urban Prenatal Clinics, American Society of Addiction Medicine Annual Conference. Orlando, Florida, 2019.
V. H. Coleman-Cowger, Oga, E. A., and Mark, K., Prenatal Polysubstance Use among Women who Report Smoking Cigarettes in the Month Prior to Pregnancy, Society for Research on Nicotine and Tobacco Annual Conference. San Francisco, California, 2019.
E. A. Oga, Peters, E. N., Mark, K., Trocin, K., and Coleman-Cowger, V. H., Prenatal Substance Use and Perceptions of Parent and Partner Use Using the 4P's Plus Screener., Matern Child Health J, vol. 23, no. 2, pp. 250-257, 2019.
J. Dow and Coleman-Cowger, V. H., Preterm Birth among African American Women: Diet and Exercise as Protective Factors, American Public Health Association Annual Meeting and Expo. Philadelphia, Pennsylvania, 2019.
V. H. Coleman-Cowger, Oga, E. A., and Mark, K., Prevalence and associated birth outcomes of co-use of cannabis and tobacco during pregnancy, Society for Research on Nicotine and Tobacco. Oceania, Sydney, Australia, 2019.
G. Lapham, Boudreau, D. M., Johnson, E. A., Bobb, J. F., Matthews, A. G., McCormack, J., Liu, D., Samet, J. H., Saxon, A. J., Campbell, C., Glass, J. E., Rossom, R. C., Murphy, M. T., Binswanger, I. A., Yarborough, B. Jo H., and Bradley, K. A., Prevalence and treatment of opioid use disorders among primary care patients in six health systems. 2019.
A. Domalpally, Agron, E., Pak, J. W., Keenan, T. D., ,, Clemons, T. E., and Chew, E. Y., Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
2018
R. J. Carter, Senesi, R. G. B., Dawson, P., Gassama, I., Kargbo, S. A. S., Petrie, C. R., Rogers, M. Hashim, Samai, M., and Luman, E. T., Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)., J Infect Dis, vol. 217, no. suppl_1, pp. S65-S74, 2018.
J. King, May, J., Salazar, D., Hoehn, A., Shmueli-Blumberg, D., Novo, P., Choi-Kuaea, Y., Peavy, K. M., Wiebe, R., Lee, J., and Rotrosen, J., Participants’ Preferences for BUP-NX or XR-NTX and Associations with Induction Success and Relapse Rates in the NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT), in College on Problems of Drug Dependence (CPDD), Portland, OR, 2018.
R. W. Frenck, Baqar, S., Alexander, W., Dickey, M., McNeal, M., El-Khorazaty, J., Baughman, H., Hoeper, A., Barnoy, S., Suvarnapunya, A. E., Kaminski, R. W., and Venkatesan, M. M., A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei., Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
M. Horwitz, Wease, S., Blackwell, B., Valcarcel, D., Frassoni, F., Boelens, J. J., Nierkens, S., Jagasia, M., Wagner, J. E., Kuball, J., Koh, L. P., Majhail, N. S., Stiff, P., Hanna, R., Hwang, W. Y. K., Kurtzberg, J., Cilloni, D., Freedman, L. S., Montesinos, P., and Sanz, G., Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide., J Clin Oncol, 2018.
P. A. Carpenter, Logan, B. R., Lee, S. J., Weisdorf, D. J., Johnston, L., Costa, L. J., Kitko, C. L., Bolaños-Meade, J., Sarantopoulos, S., Alousi, A. M., Abhyankar, S., Waller, E. K., Mendizabal, A., Zhu, J., O'Brien, K. A., Lazaryan, A., Wu, J., Nemecek, E. R., Pavletic, S. Z., Cutler, C. S., Horowitz, M. M., and Arora, M., A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801., Haematologica, vol. 103, no. 11, pp. 1915-1924, 2018.